First trial of faecal microbiota transplantation for people with active peripheral psoriatic arthritis shows no advantage

(European Alliance of Associations for Rheumatology) Results of the first trial of its kind presented at EULAR 2021 -- Targeting dysbiosis of the intestinal microbiota by faecal microbiota transplantation (FMT) has been proposed as a novel therapeutic option for people with extra-intestinal inflammatory diseases - although the link is yet to be established. In this first interventional randomized controlled trial of FMT in immune-mediated arthritis, transplantation was inferior to sham in treati...